Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRUNCATE-TB: 2-Month Regimens for Drug-Sensitive Tuberculosis
NCT03474198Phase 3Completed
- Sponsor
- University College London
- Start
- Mar 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of linezolid, clofazimine, rifapentine, levofloxacin, bedaquiline in pulmonary tuberculosis (TB), sponsored by University College London. Started Mar 2018; status: completed.
02
Drugs
linezolidclofaziminerifapentinelevofloxacinbedaquiline
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT03474198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03474198.